Levels of CD40L and other inflammatory biomarkers in obese and non-obese women with polycystic ovary syndrome

被引:6
|
作者
Sarray, Sameh [1 ]
Almawi, Wassim Y. [1 ]
机构
[1] Arabian Gulf Univ, Dept Med Biochem, Manama, Bahrain
关键词
CD40L; CRP; cytokines; polycystic ovary syndrome; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; GRADE CHRONIC INFLAMMATION; NORMAL-WEIGHT WOMEN; INSULIN-RESISTANCE; PERIPHERAL-BLOOD; CARDIOVASCULAR RISK; ADIPOSE-TISSUE; SOLUBLE CD40L; PER-SE;
D O I
10.1111/aji.12549
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Problem: We investigated whether changes in sCD40L, hs-CRP, IL-6, and TNF-alpha levels are associated with polycystic ovary syndrome (PCOS). Method of study: Case-control study involving 143 women with and 165 women without PCOS. Result(s): Reduced sCD40L, and increased hs-CRP and IL-6, but not TNF-alpha, levels were seen between cases and controls. ROC analysis demonstrated high sensitivity and specificity for sCD40L and hs-CRP as PCOS predictors. Altered sCD40L levels were associated with PCOS, irrespective of body weight. Significant differences in IL-6 levels were seen between non-obese subjects and for TNF-alpha in obese subjects. sCD40L correlated negatively with age, insulin, HOMA-IR, LH, free testosterone, FAI, and hirsutism, but positively with SHBG. CRP correlated positively with BMI, insulin, HOMA-IR, free testosterone, and hirsutism. IL-6 correlated positively with hirsutism. TNF-alpha correlated positively with age, but negatively with insulin and HOMA-IR. Conclusion: CD40L, more than IL-6, or TNF-alpha, constitutes a predictor to explain PCOS and associated features.
引用
收藏
页码:285 / 291
页数:7
相关论文
共 50 条
  • [1] Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome
    Agacayak, Elif
    Tunc, Senem Yaman
    Sak, Sibel
    Basaranoglu, Serdar
    Yuksel, Hatice
    Turgut, Abdulkadir
    Gul, Talip
    [J]. MEDICAL SCIENCE MONITOR, 2015, 21 : 2446 - 2455
  • [2] Frequency of Non-Obese Women with Polycystic Ovary Syndrome and Efficacy of Metformin in Non-Obese Women with Polycystic Ovary Syndrome
    Qadir, Sara
    Aslam, Tauqeer
    Rabbani, Maryam
    Malik, Sajid
    Rabbani, Amna
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (03): : 898 - 899
  • [3] Incretin Levels in Obese and Non-Obese Patients With Polycystic Ovary Syndrome
    Liu, Yu
    Wang, Lu
    [J]. DIABETES, 2012, 61 : A707 - A707
  • [4] Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang, Shiyuan
    Wang, Qiuyi
    Huang, Wei
    Song, Yong
    Feng, Guimei
    Zhou, Lu
    Tan, Jing
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (01) : 38 - 41
  • [5] Plasma L-carnitine levels of obese and non-obese polycystic ovary syndrome patients
    Celik, Fatih
    Kose, Mesut
    Yilmazer, Mehmet
    Koken, Gulengul N.
    Arioz, Dagistan Tolga
    Pektas, Mine Kanat
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 37 (04) : 476 - 479
  • [6] Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome
    Fenkci, Semin Melahat
    Fenkci, Veysel
    Oztekin, Ozer
    Rota, Simin
    Karagenc, Nedim
    [J]. HUMAN REPRODUCTION, 2008, 23 (07) : 1602 - 1606
  • [7] Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome
    Micic, D
    Macut, D
    Popovic, V
    SumaracDumanovic, M
    Kendereski, A
    Colic, M
    Dieguez, C
    Casanueva, FF
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 1997, 11 (05) : 315 - 320
  • [8] Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome
    Arikan, Senay
    Bahceci, Mithat
    Tuzcu, Alpaslan
    Kale, Ebru
    Gokalp, Deniz
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2010, 26 (03) : 161 - 166
  • [9] Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome
    Chen, Mei-Jou
    Yang, Wei-Shiung
    Chen, Hsin-Fu
    Kuo, Jahn-Jahn
    Ho, Hong-Nerng
    Yang, Yu-Shih
    Chen, Shee-Uan
    [J]. HUMAN REPRODUCTION, 2010, 25 (03) : 779 - 785
  • [10] Lipolytic catecholamine resistance in non-obese women with polycystic ovary syndrome
    Wahrenberg, H
    Ek, I
    Bergqvist, A
    Carlstrom, K
    Arner, P
    [J]. DIABETOLOGIA, 1997, 40 : 694 - 694